CITIUS ONCOLOGY, INC.

Nasdaq:CTOR

Pharmaceutical Preparations·CRANFORD, NJ

Governanceproxy statements · beneficial ownership

Proxy Statements

9 shown

Filed	Form	Description
1/29/26	DEF 14C	DEFINITIVE INFORMATION STATEMENT	→
1/20/26	PRE 14C	PRELIMINARY INFORMATION STATEMENT	→
9/26/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
2/24/25	DEFA14C	DEFINITIVE ADDITIONAL MATERIALS	→
2/24/25	DEF 14C	DEFINITIVE INFORMATION STATEMENT	→
2/12/25	PRE 14C	PRELIMINARY INFORMATION STATEMENT	→
↓

Ownership Filings

40 shown

Filed	Form	Description
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
↓